share_log

Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

默沙东 | S-3ASR：“知名成熟发行人”证券注册声明
SEC announcement ·  03/19 16:36
Moomoo AI 已提取核心信息
On March 19, 2024, Merck & Co., Inc., a global healthcare company based in New Jersey, filed a Form S-3 registration statement with the Securities and Exchange Commission (SEC). This registration is part of a shelf registration process, allowing the company to sell shares of its common stock from time to time as part of its Stock Investment Plan. The plan offers a convenient way for participants to purchase Merck's common stock and reinvest cash dividends in additional shares. Participation is open to any registered holder of common stock or any person who becomes a registered holder by enrolling in the plan. The prospectus details the plan's features, including automatic dividend reinvestment, optional cash investments, and full investment of plan funds...Show More
On March 19, 2024, Merck & Co., Inc., a global healthcare company based in New Jersey, filed a Form S-3 registration statement with the Securities and Exchange Commission (SEC). This registration is part of a shelf registration process, allowing the company to sell shares of its common stock from time to time as part of its Stock Investment Plan. The plan offers a convenient way for participants to purchase Merck's common stock and reinvest cash dividends in additional shares. Participation is open to any registered holder of common stock or any person who becomes a registered holder by enrolling in the plan. The prospectus details the plan's features, including automatic dividend reinvestment, optional cash investments, and full investment of plan funds. Merck's common stock is listed on the New York Stock Exchange under the symbol 'MRK.' The company intends to use the proceeds from the sale of treasury or new issue common stock for general corporate purposes. The registration statement also includes information on the federal income tax consequences for participants, the plan of distribution, and the legality of the common stock.
2024 年 3 月 19 日，总部位于新泽西州的全球医疗保健公司默沙东公司向美国证券交易委员会 (SEC) 提交了 S-3 表格注册声明。这种注册是现成注册程序的一部分，允许公司不时出售其普通股，作为其股票投资计划的一部分。该计划为参与者提供了购买默克普通股并将现金分红再投资于额外股票的便捷方式。任何注册的普通股持有人或任何通过注册该计划成为注册持有人的人都可以参与。招股说明书详细说明了该计划的特点，包括自动股息再投资、可选现金投资和计划资金的全额投资。默克的普通股在纽约证券交易所上市，股票代码为 “MRK”。该公司打算将出售国库或新发行普通股的收益用于一般公司用途。注册声明还包括有关联邦所得税对参与者的影响、分配计划和普通股合法性的信息。
2024 年 3 月 19 日，总部位于新泽西州的全球医疗保健公司默沙东公司向美国证券交易委员会 (SEC) 提交了 S-3 表格注册声明。这种注册是现成注册程序的一部分，允许公司不时出售其普通股，作为其股票投资计划的一部分。该计划为参与者提供了购买默克普通股并将现金分红再投资于额外股票的便捷方式。任何注册的普通股持有人或任何通过注册该计划成为注册持有人的人都可以参与。招股说明书详细说明了该计划的特点，包括自动股息再投资、可选现金投资和计划资金的全额投资。默克的普通股在纽约证券交易所上市，股票代码为 “MRK”。该公司打算将出售国库或新发行普通股的收益用于一般公司用途。注册声明还包括有关联邦所得税对参与者的影响、分配计划和普通股合法性的信息。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息